Logo Lanfrica

Genetic factors in acenocoumarol treatment in Tunisian patients: Personalized medicine

Creator:
M. K. S. S.
Publisher:
Elsevier BV
Host:

Licenses

https://www.elsevier.com/tdm/userlicense/1.0/https://www.elsevier.com/legal/tdmrep-licensehttp://www.elsevier.com/open-access/userlicense/1.0/

Similar

Abstract PO-131: Therapeutic molecular targets in Egyptian colorectal cancer patients: Time for ethnic personalized medicine

Abstract Background: Colorectal cancer (CRC) in Egypt is one of the most prevalent

Machine Learning for Personalized Medicine in Sub-Saharan Africa: A review

Personalized medicine (PM) has transformed healthcare globally by customizing treatments based on in

Evaluation of Cardiovascular Risk Factors in Tunisian Coronary Patients

CDH1 and CTNNA1 Genetic Screening in Tunisian Patients with Hereditary Diffuse Gastric Carcinoma

Abstract Background : Mutational screening of the CDH1 gene is a standard treatment f

Personalized Medicine and Chronic Kidney Disease in Sub-Saharan Africa: Advances and Challenges

Abstract Chronic kidney disease is increasing in prevalence sub-Saharan Africa, largely driven by

PB1921 COMPREHENSIVE ANALYSIS OF MOLECULAR RESPONSE IN TUNISIAN CML PATIENTS FOR TREATMENT DISCONTINUATION

Background: Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by a bala